Understanding Visceral Fat Index (VFI): Normal vs Optimal Ranges

?What is Visceral Fat Index (VFI)?

The Visceral Fat Index is a composite marker that estimates the amount of deep abdominal fat surrounding internal organs, calculated using waist circumference, BMI, triglycerides, and HDL cholesterol. Unlike subcutaneous fat (fat stored under the skin), visceral fat is metabolically active and associated with various health risks. VFI helps assess cardiometabolic risk beyond what traditional BMI measurements alone can provide.

!Why It Matters

Elevated visceral fat can be associated with insulin resistance, metabolic syndrome, cardiovascular disease, and chronic inflammation, even in individuals with normal BMI. VFI may suggest increased risk for type 2 diabetes, fatty liver disease, and adverse metabolic outcomes. Monitoring VFI can help identify hidden metabolic risk that weight alone does not capture.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Central obesity or abdominal bloating despite normal weight
• Persistent fatigue or low energy levels
• Difficulty losing weight despite diet efforts
• Increased thirst or frequent urination
• Metabolic sluggishness or difficulty concentrating

How to Improve Your Levels

• 1Engage in regular aerobic exercise (150+ minutes weekly) and resistance training to reduce visceral fat preferentially
• 2Reduce refined carbohydrates and added sugars; prioritize whole grains, fiber, and protein
• 3Incorporate anti-inflammatory foods such as fatty fish, leafy greens, berries, and olive oil
• 4Manage stress through meditation, yoga, or adequate sleep (7–9 hours nightly) to reduce cortisol-driven fat accumulation
• 5Limit alcohol consumption, particularly excess intake which promotes visceral fat deposition
• 6Increase physical activity intensity; high-intensity interval training is particularly effective for visceral fat reduction

When to Test

Annual screening for adults over 30, particularly those with central obesity, family history of metabolic disease, or existing cardiovascular or metabolic conditions. More frequent testing may be warranted when implementing lifestyle interventions to track progress.

Related Biomarkers